Kangmei Pharma | 600518 - Cost Of Sales


Kangmei Pharma reported CNY961.15M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Genomma Lab Internacional MXN 1.56B 25.42M Jun/2026
Hypermarcas BRL 807.21M 51.73M Mar/2026
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Jiangsu Hengrui CNY 1.02B 68.56M Jun/2026
Kangmei Pharma CNY 961.15M 119.7M Jun/2026
Moderna USD 93M 862M Jun/2026
Organon & Co USD 711M 34M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Sh Fosun Pharma CNY 5.22B 154.71M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Wuxi Apptec CNY 7.15B 983.35M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026
Zz Pientze Pharmaceu CNY 1.17B 418.33M Jun/2026